Sarepta Therapeutics Inc (SRPT)

02:37 AM

Sarepta Therapeutics (NASDAQ:SRPT) Shares Pass Above 200 Day Moving AverageHere's Why - MarketBeat

02:37 AM

Apr 14, 2026

Sarepta Therapeutics (SRPT) price target decreased by 10.97% to 22.48 - MSN

Apr 14, 2026

Apr 13, 2026

Chipmakers Recap: Can Sarepta Therapeutics Inc deliver consistent EPS growth2026 Macro Moves & Expert Verified Stock Movement Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Stock Report: Is Sarepta Therapeutics Inc vulnerable to short sellersRecession Risk & Fast Gain Stock Tips - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

Why is Sarepta Therapeutics (SRPT) up 24.2% since last earnings report? - MSN

Apr 12, 2026

Apr 12, 2026

Sarepta drops as report suggests FDA needs new trials for Elevidys - MSN

Apr 12, 2026

Apr 11, 2026

Sarepta Therapeutics (SRPT) price target decreased by 16.58% to 25.25 - MSN

Apr 11, 2026

Apr 11, 2026

Sarepta plans FDA filings seeking full approval for two DMD therapies - MSN

Apr 11, 2026

Apr 10, 2026

Sarepta Therapeutics, Inc. (SRPT) stock price, news, quote and history - Yahoo Finance Singapore

Apr 10, 2026

Apr 09, 2026

Sarepta Therapeutics, Inc. (SRPT) Stock Forecasts - Yahoo Finance

Apr 09, 2026

Apr 09, 2026

Sarepta Therapeutics, Inc. (AB3A.F) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 09, 2026

Apr 08, 2026

SRPT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 08, 2026

Apr 08, 2026

A decade ago, these drugs tore apart the FDA. Today, they might be some patients' best hope - statnews.com

Apr 08, 2026

Apr 08, 2026

Antisense Oligonucleotides Market 2026-2033 | US$ 5,286.96 - openPR.com

Apr 08, 2026

Apr 08, 2026

Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, Quote & History - ca.finance.yahoo.com

Apr 08, 2026

Apr 08, 2026

Sarepta siRNA Data Adds New Pillar To Rare Disease Pipeline Narrative - Yahoo Finance

Apr 08, 2026

Apr 08, 2026

Is Sarepta Therapeutics (SRPT) Starting To Look Interesting Again After Recent Share Price Rebound - Sahm

Apr 08, 2026

Apr 07, 2026

TD Cowen Downgrades Sarepta Therapeutics (SRPT) Stock to Hold, Reduces PT - MSN

Apr 07, 2026

Apr 07, 2026

9 Health Care Stocks With Whale Alerts In Today's Session - Benzinga

Apr 07, 2026

Apr 07, 2026

RBC Adjusts Price Target on Sarepta Therapeutics to $19 From $18, Maintains Sector Perform Rating - Moomoo

Apr 07, 2026

Apr 07, 2026

How The Sarepta Therapeutics (SRPT) Investment Story Is Shifting On Mixed Elevidys And Pipeline Views - Yahoo Finance

Apr 07, 2026

Apr 07, 2026

Trading the Move, Not the Narrative: (SRPT) Edition - Stock Traders Daily

Apr 07, 2026

Apr 07, 2026

Duchenne Muscular Dystrophy Therapeutics Market to Reach USD - openPR.com

Apr 07, 2026

Apr 06, 2026

Income Plays: What is the PEG ratio of Sarepta Therapeutics Inc2026 PreEarnings & Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Apr 06, 2026

Apr 05, 2026

Sarepta Therapeutics (SRPT) Is Up 16.3% After Early siRNA Muscle Data Validates Avß6 Platform - Sahm

Apr 05, 2026

Apr 04, 2026

Aberdeen Group Boosts Stake in Sarepta Therapeutics - National Today

Apr 04, 2026

Apr 04, 2026

Aberdeen Group plc Increases Stake in Sarepta Therapeutics, Inc. $SRPT - MarketBeat

Apr 04, 2026

Apr 03, 2026

The Precedent: Federal Circuit Upholds Gene Therapy Host Cell Claims Under 35 U.S.C. § 101 in Regenxbio Inc., Et Al. v. Sarepta Therapeutics, Inc., Et Al. - JD Supra

Apr 03, 2026

Apr 03, 2026

SG Americas Securities Trims Sarepta Therapeutics Stake - National Today

Apr 03, 2026

Apr 03, 2026

SG Americas Securities LLC Lowers Holdings in Sarepta Therapeutics, Inc. $SRPT - MarketBeat

Apr 03, 2026

Apr 03, 2026

Sarepta gets New Zealand approval for Huntington’s disease trial - Investing.com

Apr 03, 2026

Apr 02, 2026

Sarepta Therapeutics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 02, 2026

Apr 02, 2026

SAREPTA THERAPEUTICS INC (1SRPT.MI) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 02, 2026

Apr 02, 2026

Wealth Enhancement Advisory Services LLC Acquires 62,981 Shares of Sarepta Therapeutics, Inc. $SRPT - MarketBeat

Apr 02, 2026

Apr 02, 2026

Wells Fargo Remains a Buy on Sarepta Therapeutics (SRPT) - The Globe and Mail

Apr 02, 2026

Apr 02, 2026

Sarepta Therapeutics, Inc. (SRPT) Stock forecasts - uk.finance.yahoo.com

Apr 02, 2026

Apr 02, 2026

SRPT Stock Price, Quote & Chart | SAREPTA THERAPEUTICS INC (NASDAQ:SRPT) - ChartMill

Apr 02, 2026

Apr 01, 2026

Sarepta Therapeutics, Inc. (0L35.L) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 01, 2026